On Monday, Shares of Staples, Inc. (NASDAQ:SPLS), gained 2.15% to $14.26.
The winners of the inaugural Crowd2Shelf Contest debut on Staples’ new entrepreneurial store at Staples.com/fundable. Created by Fundable and sponsored by Staples, the Crowd2Shelf Contest drew thousands of startups across the country competing for a chance to crowdfund their way to Staples. The Crowd2Shelf Contest was also made possible by the business strategy firm Sprosty Network.
Contestants demonstrated demand for their innovative products by gathering votes and crowdfunding pledges. A panel of innovation experts, counting Fundable and Staples representatives, chose the winners based on votes, success of crowdfunding campaigns, and each judges’ understanding of what it takes for a startup to be successful.
Staples, Inc., together with its auxiliaries, operates office products superstores. It operates through three segments: North American Stores & Online, North American Commercial, and International Operations.
Shares of Dyax Corp. (NASDAQ:DYAX), declined -0.17% to $23.79, during its last trading session.
Dyax Corp., declared financial results for the second quarter ended June 30, 2015.
2015 Second Quarter Financial Results
Total revenues for the quarter ended June 30, 2015 were $26.4 million, as contrast to $19.6 million for the comparable quarter in 2014. The second quarter 2015 revenues comprised of $17.8 million of KALBITOR net sales, as contrast to $16.6 million for the same period in 2014, as well as royalties of about $4.4 million based on sales of Eli Lilly and Company’s CYRAMZA (ramucirumab). For the six months ended June 30, 2015, total revenues were $46.8 million, contrast to $33.7 million for the same period in 2014. The six-month 2015 revenues comprised of $33.8 million of KALBITOR net sales, as contrast to $29.1 million in the 2014 period, in addition to CYRAMZA royalties of about $7.8 million. The third quarter of 2014 was the first period in which we recorded royalty revenue
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. It offers KALBITOR for the treatment of acute attacks of HAE.
Finally, FedEx Corporation (NYSE:FDX), ended its last trade with 1.44% gain, and closed at $169.40.
FedEx Office, a world-class commercial print provider, has created a faster, cost-effective and streamlined way to deliver professional print services using EFI’s industry-leading productivity software.
The EFI software system directs large or complex print jobs to the numerous FedEx Office Centralized Production Centers (CPCs). FedEx Office team members at the Network Fulfillment Center can now quickly view and assess the print production volume within the network, and easily direct print jobs to more than 100 color and monochrome digital presses across the country. The improved system has raised production efficiency by more than 15 percent.
FedEx Corporation provides transportation, e-commerce, and business services in the United States and internationally. The company’s FedEx Express segment provides various shipping services for the delivery of packages and freight; international trade services specializing in customs brokerage, and ocean and air freight forwarding services; international trade advisory services, such as assistance with the customs-trade partnership against terrorism program; and customs clearance services, in addition to global trade data, an information tool that allows customers to track and manage imports.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
